WO1988007869A3 - ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE - Google Patents
ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE Download PDFInfo
- Publication number
- WO1988007869A3 WO1988007869A3 PCT/BE1988/000011 BE8800011W WO8807869A3 WO 1988007869 A3 WO1988007869 A3 WO 1988007869A3 BE 8800011 W BE8800011 W BE 8800011W WO 8807869 A3 WO8807869 A3 WO 8807869A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gamma
- interferon
- antibodies
- therapeutic application
- immunoglobulin
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 206010063094 Cerebral malaria Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000008070 Interferon-gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229960003130 interferon gamma Drugs 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Immunoglobuline ayant une activité d'anticorps neutralisant dressée contre l'interféron gamma se trouvant chez l'homme et l'animal, destinée à être utilisée à titre d'agent thérapeutique, de substance active pour inhiber des réactions inflammatoires, empêcher ou inhiber la malaria cérébrale, et comme préparation médicale ou vétérinaire comprenant un excipient acceptable d'immunoglobuline.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8700927 | 1987-04-16 | ||
NL8700927A NL8700927A (nl) | 1987-04-16 | 1987-04-16 | Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1988007869A2 WO1988007869A2 (fr) | 1988-10-20 |
WO1988007869A3 true WO1988007869A3 (fr) | 1988-11-17 |
Family
ID=19849883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BE1988/000011 WO1988007869A2 (fr) | 1987-04-16 | 1988-04-18 | ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE |
Country Status (2)
Country | Link |
---|---|
NL (1) | NL8700927A (fr) |
WO (1) | WO1988007869A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
GB8905400D0 (en) * | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
DK195089A (da) * | 1989-04-20 | 1990-10-21 | Morten Bagge Hansen | Regulatoriske proteiner |
IT1231727B (it) * | 1989-08-11 | 1991-12-21 | Enrico Savoldi | Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone. |
DK96493D0 (da) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
US20020025316A1 (en) | 1995-08-18 | 2002-02-28 | Ferguson Mark Williams James | Pharmaceutical composition containing inhibitors of interferon-gamma |
GB2304342A (en) * | 1995-08-18 | 1997-03-19 | Univ Manchester | Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma |
DK1137766T3 (da) | 1998-12-09 | 2006-01-30 | Protein Design Labs Inc | Anvendelse af IL-12-antistoffer til behandling af psoriasis |
US7335743B2 (en) | 2002-10-16 | 2008-02-26 | Amgen Inc. | Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0088540A2 (fr) * | 1982-02-22 | 1983-09-14 | Biogen, Inc. | Séquences d'ADN, molécules d'ADN recombinant et procédure pour la production de polypeptides semblables à l'interféron humain immun |
-
1987
- 1987-04-16 NL NL8700927A patent/NL8700927A/nl not_active Application Discontinuation
-
1988
- 1988-04-18 WO PCT/BE1988/000011 patent/WO1988007869A2/fr unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0088540A2 (fr) * | 1982-02-22 | 1983-09-14 | Biogen, Inc. | Séquences d'ADN, molécules d'ADN recombinant et procédure pour la production de polypeptides semblables à l'interféron humain immun |
Also Published As
Publication number | Publication date |
---|---|
WO1988007869A2 (fr) | 1988-10-20 |
NL8700927A (nl) | 1988-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8467767A0 (it) | Preparati farmaceutici ad attivita antimicrobica e procedimento per laloro preparazione | |
GR3015241T3 (en) | Pesticidal system. | |
NO882406D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser. | |
WO1988007869A3 (fr) | ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
AU8439998A (en) | Compounds | |
EP0019403A3 (en) | Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal | |
AU591046B2 (en) | Physiologically active agent for agricultural use | |
IT1178044B (it) | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina | |
DE3164719D1 (en) | Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation | |
AU3228489A (en) | Treatment of equine livestock | |
GR860009B (en) | Preparations with retardable activity method for their preparation thereof and agent for human and especially veterinary application | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
AU591017B2 (en) | Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient | |
DK0659341T3 (da) | Fast insecticidt præparat | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
ZA845682B (en) | Benzamidine derivatives having an antimicrobial activity process for their preparation and use as disinfectant drugs or preservatives | |
NO304518B1 (no) | Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem | |
AU2366388A (en) | A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
Kamat | Effects of small doses of anticholinergic agent on EEG auditory evoked responses and behavior of cats. | |
AU1370188A (en) | Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance | |
AU632287C (en) | Pharmaceutical preparation for treatment of mastitis in animals and humans | |
AU4183589A (en) | Pharmaceutical preparation for treatment of mastitis in animals and humans | |
NO880495D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-dethia-2-thia-cefalosporinsyrederivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG |